SGD Pharma and Prince launch sterile Type I glass nasal vials for the US market, targeting complex chronic conditions like ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

The small-cap healthcare company’s market value has risen from about ₹7 crore in 2021 to nearly ₹1,837 crore as it moves into ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...

Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space Stephen Ranjan learned how to be innovative while growing up ...

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") ...

Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...